| P2093 | author name string | Rao S | |
| | Patole S | |
| | Doherty D | |
| P2860 | cites work | Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids | Q68906303 |
| | Gastrointestinal motor effects of erythromycin | Q68919025 |
| | Erythromycin is a motilin receptor agonist | Q69733507 |
| | Structure-activity relation among macrolide antibiotics in initiation of interdigestive migrating contractions in the canine gastrointestinal tract | Q70067747 |
| | Development of intestinal regulatory peptides in the human fetus | Q70231103 |
| | Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog | Q70697508 |
| | Gastric emptying in infants fed human milk or infant formula | Q71058526 |
| | Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach | Q71776039 |
| | Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants | Q72378419 |
| | Erythromycin improves gastrointestinal motility in extremely low birthweight infants | Q72515818 |
| | Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease | Q72780192 |
| | Erythromycin increases gastric antral motility in human premature infants | Q72927638 |
| | Erythromycin treatment for gastrointestinal dysmotility in preterm infants | Q73327697 |
| | Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates? | Q73488995 |
| | Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants | Q73667278 |
| | Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis | Q74387058 |
| | Erythromycin for feeding intolerance in preterm infants | Q30867492 |
| | Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging | Q34051652 |
| | Growth patterns of extremely low-birth-weight hospitalized preterm infants | Q34529223 |
| | Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides | Q34532795 |
| | Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. | Q34560412 |
| | The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? | Q34967021 |
| | Two-year outcome of infants weighing 600 grams or less at birth and born 1994 through 1998. | Q35041055 |
| | Prediction of extrauterine growth retardation (EUGR) in VVLBW infants | Q35171185 |
| | Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial | Q35287526 |
| | Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants | Q35290712 |
| | Postnatal growth retardation: a universal problem in preterm infants | Q35295337 |
| | Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut | Q35641113 |
| | Parenteral nutrition associated liver disease | Q35682617 |
| | Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis | Q35870969 |
| | The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine | Q37045047 |
| | Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis | Q39579851 |
| | Necrotizing enterocolitis: treatment based on staging criteria | Q39587732 |
| | Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature | Q40664999 |
| | Erythromycin and other macrolides as prokinetic agents | Q40786851 |
| | Longitudinal growth of hospitalized very low birth weight infants | Q40803286 |
| | Erythromycin in neonatal postoperative intestinal dysmotility | Q42701649 |
| | Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans | Q43087399 |
| | A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants | Q43724019 |
| | Infection rates in surgical neonates and infants receiving parenteral nutrition: a five-year prospective study | Q43821388 |
| | Effect of erythromycin on gastroduodenal contractile activity in developing neonates | Q43830668 |
| | Establishing Enteral Feeding in Preterm Infants with Feeding Intolerance: A Randomized Controlled Study of Low-dose Erythromycin | Q44634277 |
| | The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children | Q45918719 |
| | Studies of feeding intolerance in very low birth weight infants: definition and significance | Q47191561 |
| | Effect of erythromycin on feeding intolerance in very low birth weight infants: a preliminary observation. | Q47276584 |
| | Extrauterine growth restriction remains a serious problem in prematurely born neonates | Q47937739 |
| | Gestational evolution of small intestine motility in preterm and term infants. | Q50799276 |
| | Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants. | Q51534522 |
| | Slow infusion feedings enhance duodenal motor responses and gastric emptying in preterm infants. | Q51569090 |
| | Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility. | Q51575959 |
| | Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination. | Q51606606 |
| | Maturation of antroduodenal motor activity in preterm and term infants | Q51607353 |
| | Gastroduodenal motility in neonates: response to human milk compared with cow's milk formula. | Q51628623 |
| | The interdigestive myo-electric complex of the stomach and small bowel of dogs | Q51673854 |
| | Enteral feeding of preterm neonates: a survey of Australian neonatologists. | Q51981329 |
| | Erythromycin induces migrating motor complex in human gastrointestinal tract. | Q53862377 |
| | Postnatal Malnutrition and Growth Retardation: An Inevitable Consequence of Current Recommendations in Preterm Infants? | Q61850594 |
| | Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies | Q68741659 |
| P433 | issue | 4 | |
| P921 | main subject | erythromycin | Q213511 |
| P304 | page(s) | F301-6 | |
| P577 | publication date | 2005-05-17 | |
| P1433 | published in | Archives of Disease in Childhood. Fetal and Neonatal Edition | Q15752271 |
| P1476 | title | Erythromycin as a prokinetic agent in preterm neonates: a systematic review | |
| P478 | volume | 90 | |